These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6105775)

  • 21. gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra.
    Worms P; Depoortere H; Durand A; Morselli PL; Lloyd KG; Bartholini G
    J Pharmacol Exp Ther; 1982 Mar; 220(3):660-71. PubMed ID: 6278129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increase in striatal acetylcholine levels by GABAergic agents: dependence on corticostriatal neurons.
    Scatton B; Bartholini G
    Brain Res; 1980 Oct; 200(1):174-8. PubMed ID: 6774796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interrelations between dopaminergic and GABA-ergic transmitter mechanisms in apomorphine stereotypy.
    Markovska V; Georgiev V
    Acta Physiol Pharmacol Bulg; 1982; 8(3):67-73. PubMed ID: 6820612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopaminergic control of the septal-hippocampal cholinergic pathway.
    Robinson SE; Malthe-Sørenssen D; Wood PL; Commissiong J
    J Pharmacol Exp Ther; 1979 Mar; 208(3):476-9. PubMed ID: 430364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Current theories on the role of dopamine in the mechanism of action of neuroleptic drugs].
    Płaźnik A; Kostowski W
    Psychiatr Pol; 1984; 18(1):39-47. PubMed ID: 6146150
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
    Zharkovskiĭ AM; Matvienko OA; Nurk AM
    Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine and acetylcholine cell density in the neuroleptic responsive (NR) and neuroleptic nonresponsive (NNR) lines of mice.
    Hitzemann R; Qian Y; Hitzemann B
    J Pharmacol Exp Ther; 1993 Jul; 266(1):431-8. PubMed ID: 8101223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A dopamine-acetylcholine cascade: simulating learned and lesion-induced behavior of striatal cholinergic interneurons.
    Tan CO; Bullock D
    J Neurophysiol; 2008 Oct; 100(4):2409-21. PubMed ID: 18715897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of striatal injections of dopaminergic, cholinergic and GABAergic drugs upon swimming behavior of rats.
    Vrijmoed-de Vries MC; Cools AR
    Brain Res; 1986 Jan; 364(1):77-90. PubMed ID: 3004649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neuroendocrine modulation of haloperidol-induced catalepsy].
    Speciale C; Ferrara N; Sortino MA; Giammona G; Bernardini R; De Simone D; Marano P
    Boll Soc Ital Biol Sper; 1983 Jan; 59(1):51-7. PubMed ID: 6303368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progesterone attenuates neuroleptic-induced orofacial dyskinesia via the activity of its metabolite, allopregnanolone, a positive GABA(A) modulating neurosteroid.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):451-61. PubMed ID: 17988775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The biochemical effects of a new antidepressive, metapramine (RP 19560) on activity of the dopaminergic and cholinergic systems of the rat striatum].
    Boireau A; Garret C; Blanchard JC
    J Pharmacol; 1986; 17(1):75-84. PubMed ID: 2872367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intermittent morphine administration induces a long-lasting synergistic effect of corticosterone on dopamine D1 receptor functioning in rat striatal GABA neurons.
    Schoffelmeer AN; De Vries TJ; Vanderschuren LJ; Tjon GH; Nestby P; Wardeh G; Mulder AH
    Synapse; 1997 Apr; 25(4):381-8. PubMed ID: 9097397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticholinergic properties of antipsychotic drugs and their relation to extrapyramidal side-effects.
    Sayers AC; Bürki HR; Ruch W; Asper H
    Psychopharmacology (Berl); 1976 Dec; 51(1):15-22. PubMed ID: 13446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is dopamine-sensitive adenylate cyclase involved in regulating the activity of striatal cholinergic neurons?
    Euvrard C; Premont J; Oberlander C; Boissier JR; Bockaert J
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Nov; 309(3):241-5. PubMed ID: 530305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction of dopaminergic and cholinergic neurons in the extrapyramidal and limbic systems.
    Bartholini G; Stadler H; Gadea-Ciria M; Lloyd KG
    Adv Biochem Psychopharmacol; 1977; 16():391-5. PubMed ID: 18888
    [No Abstract]   [Full Text] [Related]  

  • 37. Decrease in rat striatal acetylcholine levels by some direct- and indirect-acting dopaminergic antagonists.
    Consolo S; Ladinsky H; Bianchi S
    Eur J Pharmacol; 1975; 33(2):345-51. PubMed ID: 1183479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GABA receptor agonists: pharmacological spectrum and therapeutic actions.
    Bartholini G
    Med Res Rev; 1985; 5(1):55-75. PubMed ID: 2984490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of dopaminergic activity in the extrapyramidal and limbic systems by gamma-acetylenic GABA [proceedings].
    Huot S; Lippert B; Palfreyman MG; Schechter PJ
    Br J Pharmacol; 1977 Jun; 60(2):264P-265P. PubMed ID: 880435
    [No Abstract]   [Full Text] [Related]  

  • 40. The potential of GABA-mimetics in the therapy of extrapyramidal disorders.
    Bartholini G; Lloyd KG
    J Neural Transm Suppl; 1980; (16):229-38. PubMed ID: 6107332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.